Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

Conditions: Malignant Mesothelioma; Colorectal Cancer; Bile Duct Cancer; Rectal Cancer; Ovary Cancer; Pancreatic Cancer; Breast Cancer Female Interventions: Biological: UCMYM802 Injection Sponsors: UTC Therapeutics Inc.; Peking University Cancer Hospital& Institute Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials